loadpatents
Patent applications and USPTO patent grants for KYOTO PHARMACEUTICAL UNIVERSITY.The latest application filed is for "kidney-targeting drug delivery carrier".
Patent | Date |
---|---|
Kidney-targeting Drug Delivery Carrier App 20220040109 - Katsumi; Hidemasa ;   et al. | 2022-02-10 |
Method For Producing Radioactive Composition App 20210387197 - MOGI; Katsuo ;   et al. | 2021-12-16 |
Complex Capable Of Inhibiting Genetic Function In Exosome, And Cancer Proliferation And/or Metastasis Suppressor App 20210299267 - YAMAYOSHI; Asako ;   et al. | 2021-09-30 |
Kidney-targeting Drug Delivery Carrier App 20200237669 - Katsumi; Hidemasa ;   et al. | 2020-07-30 |
Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof Grant 10,550,153 - Hayashi , et al. Fe | 2020-02-04 |
Peptide Or Pharmaceutically Acceptable Salt Thereof, Or Prodrug Thereof App 20190359652 - HAYASHI; Yoshio ;   et al. | 2019-11-28 |
NCAGE Code | SHQS0 | Kyoto Pharmaceutical University |
CAGE Code | SHQS0 | KYOTO PHARMACEUTICAL UNIVERSITY |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.